代谢功能障碍相关的肥胖性肝病的内镜腹疗法:机械洞察力和代谢影响
Wissam Ghusn1,2, Mira Sridharan1, Rachel Fromer1
1Department of Internal Medicine, Boston University, Boston, MA 02118, USA.
Biomedicines
|October 29, 2025
概括
透视性减肥疗法在治疗与代谢功能障碍相关的脂肪性肝病 (MASLD) 中表现有前途. 这些微创手术改善肝脏脂肪,硬度和纤维化标志物,为手术提供潜在的替代方案.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 代谢疾病 代谢疾病
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是与肥胖相关的日益严重的全球健康问题.
- 内透视减肥疗法 (EBT) 为体重控制和新陈代谢改善提供了最少的侵入性选择.
研究的目的:
- 审查目前关于MASLD的EBT的证据.
- 评估MASLD患者与EBT相关的机制和肝脏结果.
主要方法:
- 在MASLD中对EBT (ESG,IGB,DJBL,DMR) 的现有文献进行系统审查.
- 对报告肝硬化,肝硬化,纤维化生物标志物和肝酶的研究进行分析.
主要成果:
- 内镜套胃形成术 (ESG) 始终可以减少肝硬化和纤维化.
- 胃内气球 (IGB) 改善肝硬度,降低脂肪含量.
- 十二指甲-关旁路线 (DJBL) 降低肝酶,而十二指甲粘膜复苏 (DMR) 显示了纤维化混合的结果.
结论:
- EBT显示出对MASLD的潜在益处,改善了肝脏健康的关键指标.
- 需要进行更多随机对照试验,随访时间更长,以确认长期疗效,并将EBT与手术选项进行比较.
相关概念视频
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
538
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
538
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
01:29Chronic Pancreatitis II: Collaborative Care
307
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
307